Q4 2015 Holdings
Filed 2016-02-16 | 155 holdings | $31.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $13.4M | 642,047 | 43.2% |
| Aldeyra Therapeutics Inc(ALDX) | COM | 01438T106 | $8.4M | 1,240,458 | 27.1% |
| Akebia Therapeutics Inc(AKBA) | COM | 00972D105 | $3.4M | 260,000 | 10.8% |
| Catalyst Pharmaceuticals Inc(CPRX) | COM | 14888U101 | $2.1M | 851,200 | 6.7% |
| Champions Oncology Inc(CSBR) | COM NEW | 15870P307 | $1.3M | 372,597 | 4.3% |
| ANI Pharmaceuticals Inc(ANIP) | COM | 00182C103 | $578.0K | 12,800 | 1.9% |
| Charles RIV Labs Intl Inc(CRL) | COM | 159864107 | $274.0K | 3,410 | 0.9% |
| Biogen Inc(BIIB) | COM | 09062X103 | $199.0K | 648 | 0.6% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $147.8K | 15,239,444 | 0.5% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $141.2K | 2,496,167 | 0.5% |
| Cellectis S A(CLLS) | SPONSORED ADS | 15117K103 | $93.0K | 2,996 | 0.3% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $86.5K | 2,240,928 | 0.3% |
| Dyax Corp | COM | 26746E103 | $68.4K | 1,819,215 | 0.2% |
| Tesaro Inc | COM | 881569107 | $50.7K | 968,659 | 0.2% |
| Retrophin Inc | COM | 761299106 | $49.8K | 2,579,380 | 0.2% |
| Allergan PLC | SHS | G0177J108 | $45.3K | 145,000 | 0.1% |
| Global Blood Therapeutics in | COM | 37890U108 | $38.4K | 1,186,630 | 0.1% |
| Nevro Corp(NVROEUR) | COM | 64157F103 | $32.7K | 484,279 | 0.1% |
| Teva Pharmaceutical Inds LTD(TEVA) | ADR | 881624209 | $31.6K | 481,000 | 0.1% |
| Versartis Inc | COM | 92529L102 | $28.5K | 2,299,454 | 0.1% |
| GW PharmaceuticalsPut | ADS | 36197T103 | $27.8K | 400,000 | 0.1% |
| Xencor Inc(XNCR) | COM | 98401F105 | $27.1K | 1,854,784 | 0.1% |
| Ignyta Inc | COM | 451731103 | $24.3K | 1,812,060 | 0.1% |
| Lion Biotechnologies Inc | COM | 53619R102 | $23.2K | 3,000,161 | 0.1% |
| Acelrx Pharmaceuticals Inc(ACRXUSD) | COM | 00444T100 | $23.1K | 5,995,760 | 0.1% |
| Sarepta Therapeutics Inc(SRPT)Call | COM | 803607100 | $19.3K | 500,000 | 0.1% |
| Baxter Intl Inc | COM | 71813109 | $18.5K | 485,000 | 0.1% |
| Five Prime Therapeutics Inc(FPRX) | COM | 33830X104 | $18.0K | 434,129 | 0.1% |
| Applied Genetic Technol Corp(2GT) | COM | 03820J100 | $17.6K | 861,513 | 0.1% |
| LA Jolla Pharmaceutical Co(LJPC) | COM PAR $.0001 2 | 503459604 | $17.5K | 649,515 | 0.1% |
| Dermira Inc(DERMEUR) | COM | 24983L104 | $17.4K | 502,000 | 0.1% |
| Uniqure NV(QURE) | SHS | N90064101 | $16.0K | 967,093 | 0.1% |
| Quotient LTD | SHS | G73268107 | $14.3K | 893,540 | 0.0% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $13.8K | 110,000 | 0.0% |
| Acceleron Pharma Inc(XLRN) | COM | 00434H108 | $13.5K | 276,036 | 0.0% |
| Regenxbio Inc(RGNX) | COM | 75901B107 | $12.9K | 779,213 | 0.0% |
| Cidara Therapeutics Inc | COM | 171757107 | $12.7K | 742,858 | 0.0% |
| Pfenex Inc | COM | 717071104 | $11.9K | 960,877 | 0.0% |
| Eagle Pharmaceuticals Inc(EGRX) | COM | 269796108 | $11.8K | 133,145 | 0.0% |
| DBV Technologies S A | SPONSORED ADR | 23306J101 | $11.1K | 306,715 | 0.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $10.7K | 404,404 | 0.0% |
| Capital SR Living Corp | COM | 140475104 | $10.1K | 483,700 | 0.0% |
| Axovant Sciences LTD | COM | G0750W104 | $9.6K | 535,000 | 0.0% |
| Depomed Inc | COM | 249908104 | $9.1K | 500,000 | 0.0% |
| Acadia Pharmaceuticals Inc | COM | 4225108 | $8.7K | 245,240 | 0.0% |
| Bellicum Pharmaceuticals | COM | 79481107 | $8.5K | 421,188 | 0.0% |
| Amgen Inc | COM | 31162100 | $8.1K | 50,000 | 0.0% |
| VBI Vaccines | COM | 91790E102 | $8.0K | 3,260,356 | 0.0% |
| Oncothyreon Inc | COM | 682324108 | $7.6K | 3,414,121 | 0.0% |
| ANI Pharmaceuticals Inc | NOTE 3.000%12/0 | 00182CAA1 | $7.5K | $7,500,000 | 0.0% |